Paper19337019
The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.
Duran C and 8 others. J Endocrinol Invest, 2009. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients. Papers, record 19337019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19337019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acarbose | Major topic |
| Blood Glucose | Major topic |
| Carbamates | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hypoglycemic Agents | Major topic |
| Insulin | Major topic |
| Piperidines | Major topic |
| Drug Therapy, Combination | |
| Female | |
| Glycated Hemoglobin | |
| Humans | |
| Hypoglycemia | |
| Insulin Glargine | |
| Insulin, Long-Acting | |
| Male | |
| Middle Aged | |
| Obesity | |
| Weight Gain |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9839094 | Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9839094 | PubMed |
| 2 | 11315821 | Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. | Diabetes Care | 2001 | https://conductscience.org/library/papers/11315821 | PubMed |
| 3 | 7733122 | Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. | Am J Med | 1995 | https://conductscience.org/library/papers/7733122 | PubMed |
| 4 | 11221809 | Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus. | Diabetes Obes Metab | 1999 | https://conductscience.org/library/papers/11221809 | PubMed |
| 5 | 2951066 | A practical guide to basal and prandial insulin therapy. | Diabet Med | 1985 | https://conductscience.org/library/papers/2951066 | PubMed |
| 6 | 11574456 | Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes. | Diabetes Care | 2001 | https://conductscience.org/library/papers/11574456 | PubMed |
| 7 | 11815505 | Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). | Diabetes Care | 2002 | https://conductscience.org/library/papers/11815505 | PubMed |
| 8 | 7510610 | Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. | Drugs | 1993 | https://conductscience.org/library/papers/7510610 | PubMed |
| 9 | 7734015 | The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. | Ann Intern Med | 1994 | https://conductscience.org/library/papers/7734015 | PubMed |
| 10 | 12860485 | Insulin glargine: a systematic review of a long-acting insulin analogue. | Clin Ther | 2003 | https://conductscience.org/library/papers/12860485 | PubMed |
| 11 | 7587856 | Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure. | Diabetes Care | 1995 | https://conductscience.org/library/papers/7587856 | PubMed |
| 12 | 11315844 | Combination therapies with insulin in type 2 diabetes. | Diabetes Care | 2001 | https://conductscience.org/library/papers/11315844 | PubMed |
| 13 | 1406860 | Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1406860 | PubMed |
| 14 | 11323089 | Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study. | Diabetes Res Clin Pract | 2001 | https://conductscience.org/library/papers/11323089 | PubMed |
| 15 | 12823235 | Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients. | Diabet Med | 2003 | https://conductscience.org/library/papers/12823235 | PubMed |
| 16 | 15618112 | Standards of medical care in diabetes. | Diabetes Care | 2005 | https://conductscience.org/library/papers/15618112 | PubMed |
| 17 | 10466661 | Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. | Lancet | 1999 | https://conductscience.org/library/papers/10466661 | PubMed |
| 18 | 8572835 | Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. | Arch Intern Med | 1996 | https://conductscience.org/library/papers/8572835 | PubMed |
| 19 | 15334790 | Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application. | Diabetes Nutr Metab | 2004 | https://conductscience.org/library/papers/15334790 | PubMed |
| 20 | 15647580 | Insulin analogues. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15647580 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32621047 | A time to revisit the two oldest prandial anti-diabetes agents: acarbose and repaglinide. | Endocrine | 2020 | https://conductscience.org/library/papers/32621047 | PubMed |
| 24236131 | Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian. | PLoS One | 2013 | https://conductscience.org/library/papers/24236131 | PubMed |
| 22571453 | Secreted factors from adipose tissue increase adipogenic differentiation of mesenchymal stem cells. | Cell Prolif | 2012 | https://conductscience.org/library/papers/22571453 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19337019
GET https://conductscience.org/api/papers/v1/19337019/references?page=2